Sesen Bio Inc (SESN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

245 FIRST STREET CAMBRIDGE, MA 02142

Sesen Bio, Inc. is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The Company's lead program, Vicineumâ„¢, also known as VB4-845, is currently in the follow-up stage of a Phase 3 registration trial for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). In December 2020, the Company completed the BLA submission for Vicineum to the FDA. Sesen Bio retains worldwide rights to Vicineum with the exception of Greater China and the Middle East and North Africa (MENA), for which the Company has partnered with Qilu Pharmaceutical and Hikma Pharmaceuticals, respectively, for commercialization. Vicineum is a locally administered targeted fusion protein composed of an anti-EpCAM antibody fragment tethered to a truncated form of Pseudomonas Exotoxin A for the treatment of high-risk NMIBC.

Data as of 2021-10-09 10:06:33 -0400
Market Cap143.925 Million Shares Outstanding196.003 Million Avg 30-day Volume9.915 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.27 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.42301 52-week High/Low6.04 / 0.7 Next Earnings Date2021-11-08 Price to Cash FLow (P/CF) -6.3281
Data provided by IEX Cloud
View SEC Filings from SESN instead.

View recent insider trading info

Funds Holding SESN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SESN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RYU ELLY PRINCIPAL ACCOUNTING OFFICER

  • Officer
126,696 2021-10-01 2

HONIG PETER

  • Director
0 2021-07-20 2

JEWETT MICHAEL A. S.

  • Director
0 2021-07-20 2

DRAKE PATRICIA M. CHIEF COMMERCIAL OFFICER

  • Officer
1,000,000 2021-06-01 2

HENDERSON JANE

  • Director
92,500 2021-05-03 1

DUKER JAY S.

  • Director
92,500 2021-05-03 1

BOURDOW CARRIE L.

  • Director
92,500 2021-05-03 1

KEYES JASON A

  • Director
92,500 2021-05-03 1

SULLIVAN MARK GENERAL COUNSEL & SECRETARY

  • Officer
300,000 2021-02-19 1

CANNELL THOMAS R PRESIDENT AND CEO

  • Officer
  • Director
2,000,000 2021-02-19 1

FORBES MONICA CHIEF FINANCIAL OFFICER

  • Officer
580,000 2021-02-19 1

MACDONALD GLEN C CHIEF TECHNOLOGY OFFICER

  • Officer
300,000 2021-02-19 1

ANDERSON KIRSTIN PRINCIPAL ACCOUNTING OFFICER

  • Officer
50,000 2021-02-19 1

LYNCH DANIEL

  • Director
0 2019-06-19 0

DAN LESLIE

  • Director
0 2019-06-19 0

DIXON WENDY L

  • Director
0 2019-06-19 0

FITZGERALD RICHARD F CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-21 0

KIM DENNIS CHIEF MEDICAL OFFICER

  • Officer
0 2018-12-03 0

HURLY STEPHEN A PRESIDENT AND CEO

  • Officer
  • Director
0 2018-06-12 0

CHANEY PAUL G

  • Director
0 2018-06-12 0

CELNIKER ABBIE

  • Director
0 2018-06-12 0

GERTZ BARRY

  • Director
0 2017-05-19 0

MCCABE JOHN J CHIEF FINANCIAL OFFICER

  • Officer
0 2017-04-03 0

DECILLIS ARTHUR CHIEF MEDICAL OFFICER

  • Officer
0 2017-04-03 0

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2016-09-22 0

CLAIRMARK INVESTMENTS LTD.

  • 10% Owner
3,582,328 2016-09-20 0

TUBRIDY KAREN L CHIEF DEVELOPMENT OFFICER

  • Officer
0 2016-07-09 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

MVA INVESTORS, LLC

  • 10% Owner
No longer subject to file 2016-06-13 0

BERRY DAVID A

  • Director
0 2016-06-08 0

PFEFFER CARY

  • Director
0 2016-06-08 0

FURFINE ERIC STEVEN CHIEF SCIENTIFIC OFFICER

  • Officer
34,648 2015-12-28 0

JAFCO SUPER V3 INVESTMENT LIMITED PARTNERSHIP

  • 10% Owner
No longer subject to file 2015-05-08 0

PERRY GREGORY D CHIEF FINANCIAL AND BUSINESS

  • Officer
0 2015-02-26 0

LEVIN MARK J

  • Director
0 2014-03-20 0

AFEYAN NOUBAR

  • Director
0 2014-03-20 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

STARR KEVIN P

TEPPER ROBERT I

LEVIN MARK J

  • Director
  • 10% Owner
4,841,591 2014-02-11 0

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
330,708 2014-02-05 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
330,708 2014-02-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RYU ELLY - Officer PRINCIPAL ACCOUNTING OFFICER

2021-10-04 19:29:39 -0400 2021-10-01 A 115,000 a 126,696 direct -6.1856 6.5722 6.5722 6 -6.1856 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SESEN BIO INC SESN 2021-10-15 22:15:04 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 21:45:03 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 21:15:03 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 20:45:03 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 20:15:03 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 19:45:03 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 19:15:04 UTC -0.768 0.838 3700000
SESEN BIO INC SESN 2021-10-15 18:45:03 UTC -0.7635 0.8335 3700000
SESEN BIO INC SESN 2021-10-15 18:15:03 UTC -0.7635 0.8335 3700000
SESEN BIO INC SESN 2021-10-15 17:45:03 UTC -0.7635 0.8335 3700000
SESEN BIO INC SESN 2021-10-15 17:15:03 UTC -0.7635 0.8335 3800000
SESEN BIO INC SESN 2021-10-15 16:45:03 UTC -0.7616 0.8316 3800000
SESEN BIO INC SESN 2021-10-15 16:15:03 UTC -0.7616 0.8316 3800000
SESEN BIO INC SESN 2021-10-15 15:45:03 UTC -0.7616 0.8316 3800000
SESEN BIO INC SESN 2021-10-15 15:15:03 UTC -0.7616 0.8316 3800000
SESEN BIO INC SESN 2021-10-15 14:45:02 UTC -0.7288 0.7988 3800000
SESEN BIO INC SESN 2021-10-15 14:15:03 UTC -0.7288 0.7988 3800000
SESEN BIO INC SESN 2021-10-15 13:45:03 UTC -0.7288 0.7988 3900000
SESEN BIO INC SESN 2021-10-15 13:15:03 UTC -0.7288 0.7988 3800000
SESEN BIO INC SESN 2021-10-15 12:45:03 UTC -0.7288 0.7988 3900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund SESN -2888.0 shares, $-13342.56 2021-06-30 N-PORT

Elevate your investments